Oct 15, 2026 · 1h 33m
Longevity medicine collides with evidence and ethics
Part Two: Peter Attia and the Cult of Longevity
Peter Attia’s rise shows how expensive preventive medicine can turn scientific authority, aggressive testing, and elite access into a dangerous mix.
- 1Attia’s Medicine 3.0 framework packages genuine dissatisfaction with mainstream care into an aggressive, expensive longevity model.
- 2The episode challenges evidence for intensive screening, cancer claims, zone-two exercise prescriptions, and rapamycin use.
- 3Attia’s ties to Jeffrey Epstein expose how wealth and powerful patients can erode medical boundaries and amplify misinformation.
Don't miss
The discussion of Attia’s post-conviction relationship with Jeffrey Epstein reframes the episode from evidence critique into a question of professional ethics.
The brief
Robert Evans and Dr. Kaveh Hoda follow Peter Attia from medical training to McKinsey, where the discussion connects consulting culture to Purdue Pharma’s opioid work.
Attia’s return to medicine, public nutrition work, and Medicine 3.0 framework built a powerful wellness persona, but the episode questions how much the evidence supports it.
His concierge practice turns longevity into an elite service built around expensive testing, continuous glucose monitors, and aggressive prevention that cannot scale equitably.
The hosts examine claims about exercise, cancer, and rapamycin, arguing that speculative treatments and overstated certainty can make medical authority itself a source of harm.
Attia’s relationship with Jeffrey Epstein becomes the episode’s ethical pivot: wealth, fame, and access to powerful patients appear to have weakened boundaries that medicine depends on.
The final assessment is less about one questionable treatment than a broader system in which scientific credibility, elite networks, and patient satisfaction reinforce one another.
Books & mentions
Some links are affiliate links — PodLume may earn a commission if you buy.
